ICD-10 Coding for Cerebral Amyloid Angiopathy(E85.4, E85.4B, E85.4H)
Learn about cerebral amyloid angiopathy, its ICD-10 coding, documentation requirements, and clinical validation criteria.
Complete code families applicable to Cerebral Amyloid Angiopathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| I68.0 | Cerebral amyloid angiopathy | Use for sporadic CAA without systemic amyloidosis. |
|
| E85.4 | Hereditary amyloidosis | Use when CAA is due to hereditary amyloidosis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCerebral Amyloid Angiopathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Cerebral Amyloid Angiopathy.
Omitting genetic testing results for hereditary cases
Impact
Clinical: Misdiagnosis of hereditary conditions., Regulatory: Non-compliance with genetic documentation standards., Financial: Potential reimbursement issues.
Mitigation
Ensure genetic testing is ordered and results documented.
Incorrect sequencing of I68.0 before E85.4
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Sequence E85.4 first if hereditary amyloidosis is present.
Code Sequencing
Impact
Incorrect sequencing of CAA and amyloidosis codes.
Mitigation
Review coding guidelines for correct sequencing.